Accuray has given a presentation at the 10th Annual Needham Healthcare Conference on 5th April. The presentation was webcast live from the company’s website at the investor relations page, one hour after the end of the live presentation for a period of thirty days.
Accuray has developed and marketed the CyberKnife Robotic Radiosurgery system, which is the only system in the world for treating tumors in the body non-invasively. The system utilizes computer controlled robotic mobility and continual image guidance technology for tracking, detecting and correcting the tumor all through the treatment. High dose radiation could be provided with pinpoint precision, which would not damage the healthy tissue surrounding it and hence removes the need for body stabilization or invasive head frames.
Accuray, which is based in Sunnyvale in California, has developed this system and with it radiosurgery could be used on extracranial tumors along with tumors in the lung, spine, pancreas and the liver. So far the CyberKnife system has been used in the treatment of over 100,000 patients globally and 222 systems have been installed in hospitals in Asia, Europe and in the Americas.